Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Recruiting
N/A
Interventional Study
MELANOMA
SKIN NEOPLASMS
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Institute of Oncology Ljubljana · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cutaneous melanoma frequently develops cutaneous and subcutaneous metastases, which may cause significant morbidity and negatively affect quality of life. Electrochemotherapy (ECT) is an established local treatment modality for cutaneous and subcutaneous tumor lesions that combines the administration of cytotoxic drugs with the application of electric pulses to increase drug uptake into tumor cell…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* Histologically confirmed cutaneous melanoma
* Presence of cutaneous and/or subcutaneous metastases eligible for electrochemotherapy
* Candidate for electrochemotherapy with intravenous bleomycin or intratumoral cisplatin according to standard cl…
Contacts